
    
      This is an open label, dose escalation study. Cohort of 3~6 patients receive escalation doses
      of CKD-581 until the maximum toleated dose(MTD) is determined. The MTD is defiend as the dose
      preceding that at which 2 of 3 or 2 of 6 patients experience dose limiting toxicity.
    
  